Clinical Evaluation of BD Veritor SARS-CoV-2 and Flu A+B Assay for Point-Of-Care System

Differential diagnosis of COVID-19 and/or influenza (flu) at point of care is critical for efficient patient management and treatment of both these diseases. The study presented here characterizes the BD Veritor System for Rapid Detection of SARS-CoV-2 and Flu A+B (“Veritor SARS-CoV-2/Flu”) triplex...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Katherine, Ren, Huimiao, Chen, Shirley, Cooper, Charles K., Young, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045085/
https://www.ncbi.nlm.nih.gov/pubmed/35412847
http://dx.doi.org/10.1128/spectrum.01807-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045085/
https://www.ncbi.nlm.nih.gov/pubmed/35412847
http://dx.doi.org/10.1128/spectrum.01807-21

Ejemplares similares